Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedFooter updates add references to the Moffitt Clinical Trials website and H. Lee Moffitt Cancer Center and Research Institute, along with a 'Helpful Links Provided by' note. The revision marker now shows v3.6.3, replacing the previous v3.6.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe page revision tag was updated from v3.6.0 to v3.6.2, signaling a small maintenance release and version tracking for the study page.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded new user-help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updated recruitment status to No longer looking for participants. Included a Revision: v3.6.0 and minor formatting adjustments to the Intervention/Treatment header.SummaryDifference0.4%

- Check37 days agoChange DetectedThe page now displays revision v3.5.5, replacing the prior v3.5.4. This represents a minor administrative update to the page metadata rather than changes to study details.SummaryDifference0.1%

- Check44 days agoChange DetectedFooter branding and navigation elements were removed, including the Moffitt trial website link, sponsor name, and the 'Helpful Links Provided by' header. This changes how the page footer presents branding and navigation but does not alter the study details.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page revision tag was changed from v3.5.3 to v3.5.4. This indicates the ClinicalTrials.gov entry has been refreshed to reflect updates to its content or metadata.SummaryDifference0.1%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.